Literature DB >> 3876357

Human peripheral blood monocytes display surface antigens recognized by monoclonal antinuclear antibodies.

V M Holers, B L Kotzin.   

Abstract

We used monoclonal anti-nuclear autoantibodies and indirect immunofluorescence to examine normal human peripheral blood mononuclear leukocytes for the presence of cell surface nuclear antigens. Only one monoclonal anti-histone antibody (MH-2) was found to bind to freshly isolated PBL, staining approximately 10% of large cells. However, after cells were placed into culture for 16-24 h, a high percentage (up to 60%) of large-sized cells were recognized by an anti-DNA (BWD-1) and several different antihistone monoclonal antibodies (BWH-1, MH-1, and MH-2). These antibodies recognize separate antigenic determinants on chromatin and histones extracted from chromatin. None of the monoclonal autoantibodies appeared to bind to a significant percentage of cells of relatively small cell size, either before or after culture. The histone antigen-positive cells were viable, and the monoclonal antibodies could be shown to be binding to the cell surface and not to the nucleus. Further experiments, including those using aggregated Ig to block antibody binding, strongly indicated that anti-histone antibody binding was not Fc receptor mediated. Using monoclonal antibodies specific for monocytes and T cells, and complement-mediated cytotoxicity, the cells bearing histone antigens were shown to be primarily monocytes. The appearance of histone and DNA antigen-positive cells was nearly completely inhibited by the addition of low concentrations (0.25 micrograms/ml) of cycloheximide at initiation of the cultures. In contrast, little effect on the percentage of positive cells was detected if cells were exposed to high doses of gamma irradiation before culture. These data further support the existence of cell surface nuclear antigens on selected cell subsets, which may provide insight into the immunopathogenesis of systemic lupus erythematosus and related autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3876357      PMCID: PMC423964          DOI: 10.1172/JCI112100

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Certain polyclonal antinuclear antibodies cross-react with the surface membrane of human lymphocytes and granulocytes.

Authors:  O P Rekvig; K Hannestad
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Physical properties of cytoplasmic membrane-associated DNA.

Authors:  W Meinke; M R Hall; D A Goldstein; D E Kohne; R A Lerner
Journal:  J Mol Biol       Date:  1973-06-25       Impact factor: 5.469

4.  Serum factors causing impaired macrophage function in systemic lupus erythematosus.

Authors:  B O Svensson
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

5.  Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors.

Authors:  D Alarcon-Segovia; A Ruiz-Arguelles; E Fishbein
Journal:  Nature       Date:  1978-01-05       Impact factor: 49.962

6.  Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

Authors:  G C Sharp; W S Irvin; E M Tan; R G Gould; H R Holman
Journal:  Am J Med       Date:  1972-02       Impact factor: 4.965

7.  Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.

Authors:  G C Sharp; W S Irvin; C M May; H R Holman; F C McDuffie; E V Hess; F R Schmid
Journal:  N Engl J Med       Date:  1976-11-18       Impact factor: 91.245

8.  Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus.

Authors:  D Koffler; V Agnello; H G Kimkel
Journal:  Am J Pathol       Date:  1974-01       Impact factor: 4.307

9.  Monoclonal anti-histone autoantibodies derived from murine models of lupus.

Authors:  B L Kotzin; J A Lafferty; J P Portanova; R L Rubin; E M Tan
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  21 in total

1.  Idiotypic mimicry of a cell surface DNA receptor: evidence for anti-DNA antibodies being a subset of anti-anti-DNA receptor antibodies.

Authors:  R M Bennett; K A Cornell; M J Merritt; A C Bakke; D Mourich; S H Hefeneider
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

2.  A monoclonal anti-double-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex.

Authors:  L Jacob; J P Viard; B Allenet; M F Anin; F B Slama; J Vandekerckhove; J Primo; J Markovits; F Jacob; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

Review 3.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

4.  Phosphatidylserine as an anchor for plasminogen and its plasminogen receptor, histone H2B, to the macrophage surface.

Authors:  R Das; E F Plow
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

5.  The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies.

Authors:  K H Sun; W T Liu; S J Tang; C Y Tsai; S C Hsieh; T H Wu; S H Han; C L Yu
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

6.  In vitro inhibition of natural-killer-mediated lysis by chromatin fragments.

Authors:  A D Le Lann; G J Fournié; L Boissier; P L Toutain; H Benoist
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

7.  A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei.

Authors:  L Cosgrove; F Alderuccio; B H Toh; J Pedersen; A Holliday; I McKenzie
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

8.  Identification and isolation of soluble histones from bovine milk and serum.

Authors:  S Waga; E M Tan; R L Rubin
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

9.  Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-RNP IgG.

Authors:  J Ma; G V Chapman; S L Chen; G Melick; R Penny; S N Breit
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

10.  Histone H2B as a functionally important plasminogen receptor on macrophages.

Authors:  Riku Das; Tim Burke; Edward F Plow
Journal:  Blood       Date:  2007-08-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.